Analysis of treatment methods for metabolic syndrome patients
Retrospective Analysis of Outpatient Intervention Effects in Patients With Metabolic Syndrome
This study looks at how different treatments, like diet changes and medications, affect health markers in people with metabolic syndrome to help improve their care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 400 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Trial ID | NCT06182618 on ClinicalTrials.gov |
What this trial studies
This observational study conducts a retrospective analysis of clinical data from patients with metabolic syndrome who visited the outpatient department over the past decade. It compares the effects of various treatment methods, including dietary changes and medications like semaglutide and metformin, on key health indicators such as blood glucose, blood lipids, blood pressure, uric acid, and body composition. The goal is to provide evidence-based support for clinical treatment strategies for metabolic syndrome.
Who should consider this trial
Good fit: Ideal candidates are individuals with a BMI of 24 or more who have had at least two follow-up visits aimed at weight loss.
Not a fit: Patients who did not follow up regularly or had incomplete data may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could help identify the most effective treatment approaches for managing metabolic syndrome, leading to improved patient outcomes.
How similar studies have performed: Other studies have shown success in analyzing treatment effects for metabolic syndrome, making this approach both relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: • individuals who had at least a 2 follow up visits with a BMI of 24 or more with the pri-mary goal of losing weight. Exclusion Criteria: * patients did not follow-up on a monthly basis; * patients followed-up less than 1 times within 3 months; * patients having incomplete data; * patients changing their interventions during fol-low-ups
Where this trial is running
Hangzhou, Zhejiang
- The Second Affiliated Hospital, College of Medicine, Zhejiang University — Hangzhou, Zhejiang, China (Recruiting)
Study contacts
- Study coordinator: leilei wang
- Email: 2513118@zju.edu.cn
- Phone: 0571-87783851
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.